Snapshot · ASX Health Care · generated 2026-09-26 00:47 UTC

ACL.AX — Australian Clinical Labs Limited

UNDERVALUED (MOS +76.4%) · Quality 52/100

ACL.AX - Australian Clinical Labs Limited
Data generated 2026-09-26 00:47 UTC (nightly scan, universe: ASX Health Care).
Price: 2.77 AUD
Intrinsic value: 11.72 AUD
Margin of safety: +76.4%
Implied growth (reverse DCF): -20.6% (model assumes +0.0%)
Valuation: UNDERVALUED
Value Score: 36
Quality: 52/100
Moat score: 47.8 (erosion: watch)
UNDERVALUED (MOS +76.4%) - Quality 52/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ACL.AX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

2.77

Intrinsic value

11.72

Margin of safety

+76.4%

Implied growth (reverse DCF)

-20.6%

model assumes +0.0%

Value Score

Quality

Psychology

-9.3

Discovery

8.2

price/volume attention only

Moat score

47.8

erosion: watch

Value Score: top 44% of ASX Health Care · Quality: bottom 25%

Dividend: 0.13/share (TTM) · yield 4.7% · payout 108%

Open the interactive Deep Dive for ACL.AX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ACL.AX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ACL.AX undervalued?

As of 2026-09-26, ACL.AX trades at 2.77 against a computed intrinsic value of 11.72 (+76.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Australian Clinical Labs Limited's Value Score?

Australian Clinical Labs Limited's Value Score is 36 as of 2026-09-26 - it combines value, quality, crowd psychology and market attention into one number.

Does ACL.AX pay a dividend?

Yes - ACL.AX's trailing twelve-month dividend is 0.13/share, a yield of 4.7% at the current price (as of 2026-09-26).